Dividends & Income
To screen ETFs by asset class, performance, yield and more, check out the
This user currently has no profile.
Primary Business Background
Cambridge Technology Partners
KPMG Peat Marwick
Ford Motor Company
Education and Certifications
MBA Abilene Christian Unversity
BS Economics US Naval Academy
CFP - no longer maintaining certification
Individual and smal business tax preparation - no longer maintaining certification
Commodities, Developed International Markets, Dividend stock ideas & income, ETFs, Energy stocks, Gold, Mutual funds, REITs, Retirement savings, Tech stocks
Currently, there is no company profile for stem23.
Currently, there are no blog details for stem23.
Currently, there are no book details for stem23.
- If FDA has no further inquiries, expect FDA announce no later then March. Company is confident of response to FDA questions
Dec 9, 2014
RS, Excellent article! A sl...
Retirement Strategy: Adding A Stock That Acts M...
Just wondering, if MTGE wil...
American Capital Mortgage Presents Mixed Pictur...
Excellent article RS. Have ...
Coherus BioSciences: A Sharp Increase, A Sharp ...
I thought the same when rea...
Update: Assessing American Capital Agency's Res...
Blair, surprising and disap...
Venaxis: Latest Clinical Data Reveals Huge Mark...
Xignite quote data
© 2015 Seeking Alpha